Karman Holdings heads into its August 7 earnings date with short interest at its highest level in months and the stock down 11% on the week — a setup that puts the upcoming print under sharper scrutiny than the last one.
The most striking development this week is how quickly shorts have rebuilt their position. Short interest jumped 37% week-on-week to 9.3% of the free float — a move that adds roughly 3.4 million shares to the borrowed pool almost overnight. The step-change happened between July 8 and July 10, when short shares climbed from around 9 million to 12.5 million in a single session. That is a meaningful acceleration. Over the past month, the short position has grown by 42%, making KRMN one of the more aggressively reshorted names in aerospace and defense. The contrast with borrowing conditions is notable, however: the lending market is far from stressed. Availability runs at 452%, meaning there are more than four shares available to borrow for every one already lent out — well within normal range. Cost to borrow has actually fallen 21% over the week to just 0.44%, close to its lowest level in the 30-day window. This is not a squeeze setup; it is shorts building into a falling stock with easy, cheap access to borrow.
Options positioning has shifted in the same direction, though less dramatically. The put/call ratio eased to 1.09 on Tuesday from a peak above 1.25 earlier in the month — slightly below its 20-day mean of 1.11, and a touch more neutral than the past two weeks. The PCR has been running above 1.0 consistently since late June, a period that coincides almost exactly with the short interest acceleration. That combination — puts outweighing calls and a sharp rise in short positions — suggests the market leaning cautious rather than outright bearish, with options hedging complementing the short build rather than amplifying it.
The Street remains broadly constructive but has been walking down its targets. Citi trimmed its target to $76 from $97 at the start of July while holding its Buy rating — the most recent move and the most telling. Several firms cut targets in mid-May after Q1 results, with Keybanc moving from $122 to $100 and Piper Sandler from $127 to $114, both keeping Overweight ratings. The consensus mean target at roughly $103 sits more than double the current price of $45.83, a gap large enough to flag caution: targets may not have fully caught up with the stock's derating. BWS Financial maintains an outlier Sell with a $37 target. Bulls point to a backlog now above $1 billion, sole-source contract positions, and strong structural demand from hypersonics and missile defense programs. Bears are focused on integration risk from the Seemann and MSC acquisitions, near-term margin compression, and high leverage. The forward EPS growth picture is murky — the 12-month forward EPS year-on-year factor scores in the bottom decile of the universe.
Institutional flows show active buying from index and active managers. FMR added 2.5 million shares as of late May, taking a 6.3% stake. BlackRock added 510,000 shares through June, and First Trust added nearly 1.9 million shares, also through June. Vanguard initiated a position of over 4.3 million shares in Q1. That is a substantial institutional accumulation backdrop running alongside the short build — the two camps are clearly reading the same stock very differently.
The one prior earnings reaction on record after the May 12 print was a 14% single-day gain and a further 9% over the following week, suggesting bulls have been rewarded for holding through results before. The August 7 print is now the fulcrum: whether the short build at 9.3% of float and falling stock price reflect deteriorating fundamentals or an overcautious crowd will likely be answered then.
See the live data behind this article on ORTEX.
Open KRMN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
